Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
Kitty J. Jager, Csaba P. Kövesdy, Robyn G. Langham, et al.
Nephrology Dialysis Transplantation (2019) Vol. 34, Iss. 11, pp. 1803-1805
Open Access | Times Cited: 359

Showing 26-50 of 359 citing articles:

Effect of Avenciguat on Albuminuria in Patients with CKD
Hiddo J.L. Heerspink, David Cherney, Abdul Halim Abdul Gafor, et al.
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 9, pp. 1227-1239
Open Access | Times Cited: 15
Mortality, Health Care Burden, and Treatment of CKD: A Multinational, Observational Study (OPTIMISE-CKD)
Navdeep Tangri, Maria Svensson, Johan Bodegård, et al.
Kidney360 (2024) Vol. 5, Iss. 3, pp. 352-362
Open Access | Times Cited: 12
Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine
Anna Reznichenko, Viji Nair, Sean Eddy, et al.
Kidney International (2024) Vol. 105, Iss. 6, pp. 1263-1278
Open Access | Times Cited: 11
Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy
Jingjing He, Boxin Liu, Xiaofeng Du, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Patient and Clinician Perspectives: To Create a Better Future for Chronic Kidney Disease, We Need to Talk About Our Kidneys
Pamela Kushner, Jane DeMeis, Petrina Stevens, et al.
Advances in Therapy (2024) Vol. 41, Iss. 4, pp. 1318-1324
Open Access | Times Cited: 9
Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction
Tomomi Matsuoka, Masanori Abe, Hiroki Kobayashi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3745-3745
Open Access | Times Cited: 9
Neutrophil-percentage-to-albumin ratio is associated with chronic kidney disease: Evidence from NHANES 2009–2018
Jinxi Li, Ting Xiang, Xinyun Chen, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0307466-e0307466
Open Access | Times Cited: 9
Surface-Enhanced Raman Spectroscopy for the Characterization of Blood Serum Samples of Chronic Kidney Disease by Using 100 kDa
M. M. Atta, Muhammad Kashif, Muhammad Irfan Majeed, et al.
Plasmonics (2025)
Closed Access | Times Cited: 1
Association between remnant cholesterol and chronic kidney disease: Systematic review and meta‐analysis
Paschalis Karakasis, Dimitrios Patoulias, Manfredi Rizzo, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort
Emily de Souza Ferreira, Tiago Ricardo Moreira, Rodrigo Gomes da Silva, et al.
BMC Nephrology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease
Alberto Ortíz, Charles J. Ferro, Olga Balafa, et al.
Nephrology Dialysis Transplantation (2021) Vol. 38, Iss. 1, pp. 10-25
Open Access | Times Cited: 49
Nephroprotective Plants: A Review on the Use in Pre-Renal and Post-Renal Diseases
Mario Adrián Tienda-Vázquez, Zoé P. Morreeuw, Juan Eduardo Sosa‐Hernández, et al.
Plants (2022) Vol. 11, Iss. 6, pp. 818-818
Open Access | Times Cited: 33
Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study
Jilske Huijben, Anneke Kramer, Julia Kerschbaum, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 4, pp. 1027-1040
Open Access | Times Cited: 32
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association
Alberto Ortíz, Christoph Wanner, Ron T. Gansevoort, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 3, pp. 527-531
Open Access | Times Cited: 32
The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD
Irina Lousa, Flávio Reis, Alice Santos‐Silva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3284-3284
Open Access | Times Cited: 29
Reimagining Nephrology Fellowship Education to Meet the Future Needs of Nephrology
Mark E. Rosenberg, Sharon Anderson, Samira S. Farouk, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 6, pp. 816-825
Closed Access | Times Cited: 21
The prevalence of chronic kidney disease in South Africa - limitations of studies comparing prevalence with sub-Saharan Africa, Africa, and globally
Sudesh Hariparshad, Rajendra Bhimma, Louansha Nandlal, et al.
BMC Nephrology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 21
Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist
Luca Di Lullo, Carlo Lavalle, Alessia Scatena, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3992-3992
Open Access | Times Cited: 21
Deprivation and chronic kidney disease—a review of the evidence
Christopher H. Grant, Ehsan Salim, Jennifer S. Lees, et al.
Clinical Kidney Journal (2023) Vol. 16, Iss. 7, pp. 1081-1091
Open Access | Times Cited: 19
Impact of baseline kidney function on the effects of sodium‐glucose co‐transporter‐2 inhibitors on kidney and heart failure outcomes: A systematic review and meta‐analysis of randomized controlled trials
Ernesto Maddaloni, Ilaria Cavallari, Ylenia La Porta, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 5, pp. 1341-1350
Closed Access | Times Cited: 17
The Role of Gasotransmitter-Dependent Signaling Mechanisms in Apoptotic Cell Death in Cardiovascular, Rheumatic, Kidney, and Neurodegenerative Diseases and Mental Disorders
Stanislav Rodkin, Chizaram Nwosu, Alexander Sannikov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6014-6014
Open Access | Times Cited: 17
Current status and development trends in CKD with frailty research from 2000 to 2021: a bibliometric analysis
Guowei Yuan, Yaqin Yang, Yujie Lin, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 7
The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis
Phil McEwan, Peter D. Gabb, Jason A. Davis, et al.
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 12, pp. 2040-2047
Open Access | Times Cited: 7
Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Do Hyoung Kim, Young Youl Hyun, Jin Joo, et al.
Kidney Research and Clinical Practice (2024) Vol. 43, Iss. 1, pp. 8-19
Open Access | Times Cited: 6
Identification of a Novel ECM Remodeling Macrophage Subset in AKI to CKD Transition by Integrative Spatial and Single‐Cell Analysis
Yilin Zhang, Tao‐Tao Tang, Bin Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6

Scroll to top